Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Yasser Iturria‐Medina, Roberto C. Sotero, P.-J. Toussaint, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 995

Showing 1-25 of 995 citing articles:

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney, Abhay P. Sagare, Berislav V. Zloković
Nature Reviews Neurology (2018) Vol. 14, Iss. 3, pp. 133-150
Open Access | Times Cited: 2296
Blood-Brain Barrier: From Physiology to Disease and Back
Melanie D. Sweeney, Zhen Zhao, Axel Montagne, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 21-78
Open Access | Times Cited: 1670
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation, Melanie D. Sweeney, Axel Montagne, et al.
Nature Medicine (2019) Vol. 25, Iss. 2, pp. 270-276
Open Access | Times Cited: 1307
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki, Na Zhao, Thomas R. Caulfield, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 501-518
Open Access | Times Cited: 1045
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kassandra Kisler, Amy R. Nelson, Axel Montagne, et al.
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 7, pp. 419-434
Open Access | Times Cited: 1002
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
Axel Montagne, Daniel A. Nation, Abhay P. Sagare, et al.
Nature (2020) Vol. 581, Iss. 7806, pp. 71-76
Open Access | Times Cited: 953
Synergy between amyloid-β and tau in Alzheimer’s disease
Marc Aurel Busche, Bradley T. Hyman
Nature Neuroscience (2020) Vol. 23, Iss. 10, pp. 1183-1193
Closed Access | Times Cited: 869
The role of brain vasculature in neurodegenerative disorders
Melanie D. Sweeney, Kassandra Kisler, Axel Montagne, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 10, pp. 1318-1331
Open Access | Times Cited: 808
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 703
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Steven M. Greenberg, Brian J. Bacskai, Mar Hernández‐Guillamón, et al.
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 30-42
Open Access | Times Cited: 632
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Melanie D. Sweeney, Axel Montagne, Abhay P. Sagare, et al.
Alzheimer s & Dementia (2019) Vol. 15, Iss. 1, pp. 158-167
Open Access | Times Cited: 577
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Axel Montagne, Zhen Zhao, Berislav V. Zloković
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 11, pp. 3151-3169
Open Access | Times Cited: 575
Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes
Ross Nortley, Nils Korte, Pablo Izquierdo, et al.
Science (2019) Vol. 365, Iss. 6450
Open Access | Times Cited: 569
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni, Marina Boccardi, Frederik Barkhof, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 8, pp. 661-676
Open Access | Times Cited: 560
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel, Sid E. O’Bryant, José Luís Molinuevo, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 11, pp. 639-652
Open Access | Times Cited: 555
Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Jurgen A.H.R. Claassen, Dick H. J. Thijssen, Ronney B. Panerai, et al.
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1487-1559
Open Access | Times Cited: 549
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 445
Revisiting the neurovascular unit
Samantha Schaeffer, Costantino Iadecola
Nature Neuroscience (2021) Vol. 24, Iss. 9, pp. 1198-1209
Open Access | Times Cited: 435
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1
Cecilie Morland, Krister A. Andersson, Øyvind P. Haugen, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 422
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
Alexandra L. Young, Răzvan V. Marinescu, Neil P. Oxtoby, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 401
Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models
Jean C. Cruz Hernández, Oliver Bracko, Calvin J. Kersbergen, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 3, pp. 413-420
Open Access | Times Cited: 401
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Dallas P. Veitch, Michael W. Weiner, Paul Aisen, et al.
Alzheimer s & Dementia (2018) Vol. 15, Iss. 1, pp. 106-152
Closed Access | Times Cited: 397
A clinicopathological approach to the diagnosis of dementia
Fanny M. Elahi, Bruce L. Miller
Nature Reviews Neurology (2017) Vol. 13, Iss. 8, pp. 457-476
Open Access | Times Cited: 329
Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia
Jessica Duncombe, Akihiro Kitamura, Yoshiki Hase, et al.
Clinical Science (2017) Vol. 131, Iss. 19, pp. 2451-2468
Open Access | Times Cited: 319
Alzheimer’s Disease and Vascular Aging
Marta Cortés‐Canteli, Costantino Iadecola
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 8, pp. 942-951
Open Access | Times Cited: 289
Page 1 - Next Page

Scroll to top